Spoken Alpha · Executive

Stephen F Mahoney

President and CEOVRDNViridian Therapeutics, Inc.\DE

Current

Tracked since Oct 30, 2023

Tracked across 1 earnings call in our data since 2024.

Role timeline

VRDNViridian Therapeutics, Inc.\DE
Current
President and CEO
Oct 30, 2023 – Present · source: edgar_form4
DNTHDianthus Therapeutics, Inc. /DE/
See Remarks
Nov 2, 2020 – Nov 30, 2022 · source: edgar_form4
KNSAKiniksa Pharmaceuticals International, plc
President & COO
May 23, 2018 – Sep 17, 2019 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

1 call

VRDNQ1 FY2024May 8, 2024

Viridian Therapeutics, Inc.\DE